Thursday, June 21, 2007
Swiss back cervical cancer shot, UK decision soon
Switzerland has recommended that girls should be vaccinated with Gardasil, the cervical cancer shot marketed by Merck & Co Inc (MRK.N: Quote, Profile, Research) and Sanofi-Aventis SA (SASY.PA: Quote, Profile, Research) in Europe, the firms said on Monday.
The Swiss decision to offer the vaccine routinely to 11 to 14-year old girls follows similar moves by Austria, Germany, Italy, France, Norway, Luxembourg and Belgium.
Britain's Joint Committee on Vaccination and Immunisation, meanwhile, will decide on its policy at a meeting on June 20, a spokeswoman for the Department of Health said.